Clinical features and risk factors of catheter removal among 1062 episodes of peritoneal dialysis-associated peritonitis: A multicenter 7-year study
Shichen Liu
Division of Nephrology, the Second Hospital of Jilin University, Changchun, Jilin Province, China
Search for more papers by this authorLiming Yang
Division of Nephrology, First Hospital of Jilin University-the Eastern Division, Changchun, Jilin Province, China
Search for more papers by this authorXueyan Zhu
Division of Nephrology, Jilin Central Hospital, Jilin, Jilin Province, China
Search for more papers by this authorXiaoxuan Zhang
Division of Nephrology, Jilin FAW General Hospital, Changchun, Jilin Province, China
Search for more papers by this authorLingfei Meng
Division of Nephrology, the Second Hospital of Jilin University, Changchun, Jilin Province, China
Search for more papers by this authorXinyang Li
Division of Nephrology, the Second Hospital of Jilin University, Changchun, Jilin Province, China
Search for more papers by this authorJing Zhao
Division of Nephrology, the Second Hospital of Jilin University, Changchun, Jilin Province, China
Search for more papers by this authorXiaohua Zhuang
Division of Nephrology, the Second Hospital of Jilin University, Changchun, Jilin Province, China
Search for more papers by this authorCorresponding Author
Wenpeng Cui
Division of Nephrology, the Second Hospital of Jilin University, Changchun, Jilin Province, China
Correspondence
Wenpeng Cui, Division of Nephrology, the Second Hospital of Jilin University, Changchun, Jilin Province, China.
Email: [email protected]
Search for more papers by this authorShichen Liu
Division of Nephrology, the Second Hospital of Jilin University, Changchun, Jilin Province, China
Search for more papers by this authorLiming Yang
Division of Nephrology, First Hospital of Jilin University-the Eastern Division, Changchun, Jilin Province, China
Search for more papers by this authorXueyan Zhu
Division of Nephrology, Jilin Central Hospital, Jilin, Jilin Province, China
Search for more papers by this authorXiaoxuan Zhang
Division of Nephrology, Jilin FAW General Hospital, Changchun, Jilin Province, China
Search for more papers by this authorLingfei Meng
Division of Nephrology, the Second Hospital of Jilin University, Changchun, Jilin Province, China
Search for more papers by this authorXinyang Li
Division of Nephrology, the Second Hospital of Jilin University, Changchun, Jilin Province, China
Search for more papers by this authorJing Zhao
Division of Nephrology, the Second Hospital of Jilin University, Changchun, Jilin Province, China
Search for more papers by this authorXiaohua Zhuang
Division of Nephrology, the Second Hospital of Jilin University, Changchun, Jilin Province, China
Search for more papers by this authorCorresponding Author
Wenpeng Cui
Division of Nephrology, the Second Hospital of Jilin University, Changchun, Jilin Province, China
Correspondence
Wenpeng Cui, Division of Nephrology, the Second Hospital of Jilin University, Changchun, Jilin Province, China.
Email: [email protected]
Search for more papers by this authorAbstract
Introduction
Studies focusing on catheter removal and the pathogenic spectrum of peritoneal dialysis-associated peritonitis (PDAP) need to be updated.
Methods
Data were collected from four peritoneal dialysis (PD) centers. Peritonitis rates were compared using Poisson regression and Logistic regression was used to examine the risk factors for catheter removal.
Results
The PD duration (odds ratio [OR], 1.021; 95% confidence interval [CI], 1.010–1.032), number of previous PDAP episodes (OR, 1.267; 95% CI, 1.039–1.545), dialysate white cell count >100 × 106/L on Day 5 of PDAP (OR, 6.088; 95% CI, 3.277–11.312), Pseudomonas aeruginosa (OR, 4.122; 95% CI, 1.071–15.874) and polymicrobial infections (OR, 3.257; 95% CI, 1.519–6.982) were independent predictors of catheter removal (p < 0.05). The prevalence of polymicrobial peritonitis and fungal peritonitis has increased (p < 0.05).
Conclusion
Attention should be paid to patients with long PD duration or a history of previous episodes of PDAP characteristics.
CONFLICT OF INTEREST
The authors have no financial conflicts of interest to declare.
Open Research
DATA AVAILABILITY STATEMENT
Data can be obtained by contacting the corresponding author.
REFERENCES
- 1Li PK, Chow KM, Cho Y, Fan S, Figueiredo AE, Harris T, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022; 42(2): 110–53.
- 2Mehrotra R, Devuyst O, Davies SJ, Johnson DW. The current state of peritoneal dialysis. J. Am. Soc. Nephrol. 2016; 27(11): 3238–52.
- 3Barretti P. Evidence-based medicine: an update on treatments for peritoneal dialysis-related peritonitis. World J. Nephrol. 2015; 4(2): 287–94.
- 4Boudville N, Johnson DW, Zhao J, Bieber BA, Pisoni RL, Piraino B, et al. Regional variation in the treatment and prevention of peritoneal dialysis-related infections in the peritoneal dialysis outcomes and practice patterns study. Nephrol Dial Transpl. 2019; 34(12): 2118–26.
- 5Htay H, Cho Y, Pascoe EM, Hawley C, Clayton PA, Borlace M, et al. Multicentre registry data analysis comparing outcomes of culture-negative peritonitis and different subtypes of culture-positive peritonitis in peritoneal dialysis patients. Perit Dial Int. 2020; 40(1): 47–56.
- 6Chen HL, Tarng DC, Huang LH. Risk factors associated with outcomes of peritoneal dialysis in Taiwan: an analysis using a competing risk model. Medicine (Baltimore). 2019; 98(6):e14385.
- 7Htay H, Cho Y, Pascoe EM, Darssan D, Nadeau-Fredette AC, Hawley C, et al. Center effects and peritoneal dialysis peritonitis outcomes: analysis of a National Registry. Am. J. Kidney Dis. 2018; 71(6): 814–21.
- 8Ram R, Swarnalatha G, Rao CS, Naidu GD, Sriram S, Dakshinamurty KV. Risk factors that determine removal of the catheter in bacterial peritonitis in peritoneal dialysis. Perit Dial Int. 2014; 34(2): 239–43.
- 9Mishra AA, Koh AY. The microbial and host factors that govern Candida gastrointestinal colonization and dissemination. Curr Opin Microbiol. 2021; 63: 29–35.
- 10Boudville N, Kemp A, Clayton P, Lim W, Badve SV, Hawley CM, et al. Recent peritonitis associates with mortality among patients treated with peritoneal dialysis. J. Am. Soc. Nephrol. 2012; 23(8): 1398–405.
- 11Perl J, Fuller DS, Bieber BA, Boudville N, Kanjanabuch T, Ito Y, et al. Peritoneal dialysis-related infection rates and outcomes: results from the peritoneal dialysis outcomes and practice patterns study (PDOPPS). Am. J. Kidney Dis. 2020; 76(1): 42–53.
- 12Sakurada T, Fujishima R, Yamada S, Kohatsu K, Kojima S, Koitabashi K, et al. Seasonality of peritoneal dialysis-related peritonitis in Japan: a single-center, 10-year study. Clin Exp Nephrol. 2021; 25(1): 52–7.
- 13Mudge DW, Boudville N, Brown F, Clayton P, Duddington M, Holt S, et al. Peritoneal dialysis practice in Australia and New Zealand: a call to sustain the action. Nephrol Ther. 2016; 21(7): 535–46.
10.1111/nep.12731 Google Scholar
- 14Kang M, Kim YL, Kang E, Ryu H, Kim YC, Kim DK, et al. Evolving outcomes of peritoneal dialysis: secular trends at a single large center over three decades. Kidney Res Clin Pract. 2021; 40(3): 472–83.
- 15Santos JE, Rodríguez Magariños C, García Gago L, Astudillo Jarrín D, Pértega S, Rodríguez-Carmona A, et al. Long-term trends in the incidence of peritoneal dialysis-related peritonitis disclose an increasing relevance of streptococcal infections: a longitudinal study. PLoS One. 2020; 15(12):e0244283.
- 16Hwang TY, Kim MG, Oh SW, Jo SK, Cho WY, Yang J. Pathogens of peritoneal dialysis peritonitis: trends from a single-center experience over 15 years. Kidney Res Clin Pract. 2020; 39(2): 221–7.
- 17Hu S, Ming P, Qureshi AR, Lindholm B, Bo Y, Yang H. Peritonitis: episode sequence, microbiological variation, risk factors and clinical outcomes in a North China peritoneal dialysis center. Kidney Blood Press Res. 2018; 43(5): 1573–84.
- 18Yoon SH, Choi NW, Yun SR. Detecting bacterial growth in continuous ambulatory peritoneal dialysis effluent using two culture methods. Korean J Intern Med. 2010; 25(1): 82–5.
- 19Chao CT, Lee SY, Yang WS, Chen HW, Fang CC, Yen CJ, et al. Acinetobacter peritoneal dialysis peritonitis: a changing landscape over time. PLoS One. 2014; 9(10):e110315.
- 20Lu W, Kwan BC, Chow KM, Pang WF, Leung CB, Li PK, et al. Peritoneal dialysis-related peritonitis caused by Pseudomonas species: Insight from a post-millennial case series. PLoS One. 2018; 13(5):e0196499.
- 21Kanj SS, Kanafani ZA. Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. Mayo Clin Proc. 2011; 86(3): 250–9.
- 22Fahim M, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Coagulase-negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 936 cases. Nephrol Dial Transplant. 2010; 25(10): 3386–92.
- 23Zelenitsky SA, Howarth J, Lagace-Wiens P, Sathianathan C, Ariano R, Davis C, et al. Microbiological trends and antimicrobial resistance IN peritoneal dialysis-related peritonitis, 2005 to 2014. Perit Dial Int. 2017; 37(2): 170–6.
- 24Liu M, Yang L, Zhu X, Zhang X, Zhang Y, Zhuang X, et al. Risk factors of occurrence and treatment failure of peritoneal dialysis-associated polymicrobial peritonitis: a multicenter retrospective study. Nan fang yi ke xue xue bao = J. South. Med. Univ. 2021; 41(9): 1350–7.
- 25Barraclough K, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes. Am J Kidney Dis. 2010; 55(1): 121–31.
- 26Kim GC, Korbet SM. Polymicrobial peritonitis in continuous ambulatory peritoneal dialysis patients. Am. J. Kidney Dis. 2000; 36(5): 1000–8.
- 27Zhao J, Yang L, Zhu X, Zhang X, Li X, Liu S, et al. Clinical characteristics and treatment outcomes of first peritonitis in patients receiving long-term peritoneal dialysis: a multicenter study. Nan fang yi ke xue xue bao = J. South. Med. Univ. 2020; 40(12): 1740–6.
- 28Parikova A, Hruba P, Krediet RT, Krejcik Z, Stranecky V, Striz I, et al. Long-term peritoneal dialysis treatment provokes activation of genes related to adaptive immunity. Physiol Res. 2019; 68(5): 775–83.
- 29Devuyst O, Margetts PJ, Topley N. The pathophysiology of the peritoneal membrane. J. Am. Soc. Nephrol. 2010; 21(7): 1077–85.
- 30Hu S, Tong R, Bo Y, Ming P, Yang H. Fungal peritonitis in peritoneal dialysis: 5-year review from a North China center. Infection. 2019; 47(1): 35–43.
- 31Li R, Zhang D, He J, Ou J, Zhang L, Hu X, et al. Characteristics analysis, clinical outcome and risk factors for fungal peritonitis in peritoneal dialysis patients: a 10-year case-control study. Front Med. 2021; 8:774946.
Citing Literature
